Hollie Franklin, Author at Drugs in Context

Celebrating milestones and embracing innovation: the next chapter for Drugs in Context

Sarah L Anderson, Arduino A Mangoni, Tiago Torres

Article Type

Editorial

Published

29 Aug 2025

The Senior Editors of Drugs in Context are excited to announce that the journal received its first Impact Factor of 2.8 in the 2025 Edition of Journal Citation Reports by Clarivate.

Dupilumab reduces patient-reported cough and improves quality of life in patients with severe eosinophilic asthma with or without chronic rhinosinusitis with nasal polyps: a real-life prospective study

Carlo Lombardi, Alvise Berti, Francesco Menzella, Marcello Cottini

Article Type

Original Research

Published

26 Aug 2025

The objective of this study was to assess the impact of dupilumab on chronic cough in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps.

Properties and potentialities of hyaluronic acid and eXcellent Tridimensional Reticulation as a filling agent: a review

Vincent Wong, Martina Manni

Article Type

Review

Published

13 Aug 2025

This review summarizes the most relevant novelties in the field of HA fillers, focusing on the properties and potentialities of HA and XTR™ in the treatment of skin ageing.

Use of safinamide for treatment of Parkinson disease: real-world data from Spain

María Isabel Morales Casado, Nuria López Ariztegui

Article Type

Review

Published

25 Jul 2025

This article collects and reviews reports from Spanish authors presented at national and international conferences on the use of safinamide in patients with Parkinson disease.

Emerging concepts in obesity management: focus on glucagon receptor agonist combinations

Sarah L Anderson

Article Type

Review

Published

24 Jul 2025

This narrative review provides a comprehensive examination of the current landscape of GCGR-based combinations in phase III trials for the treatment of obesity.